Aniracetam is a nootropic compound belonging to the racetam family. It is used primarily for its cognitive-enhancing effects, including improvements in memory, learning, and focus.
Aniracetam is known to modulate AMPA receptors, enhance cholinergic and glutamatergic neurotransmission, and exhibit anxiolytic properties.
It has shown potential in treating cognitive disorders, including dementia and Alzheimer’s disease, and has been studied for its neuroprotective and anti-anxiety effects. Common side effects are mild, but its long-term safety profile remains under investigation.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | aniracetam, Draganon, Sarpul, 1-(4-Methoxybenzoyl)-2-pyrrolidinone |
|---|---|
| IUPAC Name | 1-(4-methoxybenzoyl)pyrrolidin-2-one |
| CAS | 72432-10-1 |
| Molecular Weight | 219.24 |
| Molecular Formula | C12H13NO3 |
| SMILES | COC1=CC=C(C=C1)C(=O)N2CCCC2=O |